Physiological and pathological aspects of the effect of human chorionic gonadotropin on the thyroid.
Human chorionic gonadotropin (hCG) is a glycoprotein hormone that has structural similarity to TSH. At the time of the peak hCG levels in normal pregnancy, serum TSH levels fall and bear a mirror image to the hCG peak. This reduction in TSH suggests that hCG causes an increased secretion of T4 and T3. Women with hyperemisis gravidarum often have high hCG levels that cause transient hyperthyroidsm. In the vast majority of such patients, there will be spontaneous remission of the increased thyroid function when the vomiting stops in several weeks. When there are clinical features of hyperthyroidism, it is be reasonable to treat with antithyroid drugs or a beta-adrenergic blocker, but treatment is rarely required beyond 22 weeks of gestation. Hyperthyroidism or increased thyroid function has been reported in many patients with trophoblastic tumors, either hydatiditform mole or choriocarcinoma. The diagnosis of hydatidiform mole is made by ultrasonography that shows a 'snowstorm' appearance without a fetus. Hydatidiform moles secrete large amounts of hCG proportional to the mass of the tumor. The development of hyperthyroidism requires hCG levels of >200 U/ml that are sustained for several weeks. Removal of the mole cures the hyperthyroidism. There have been many case reports of hyperthyroidism in women with choriocarcinoma and high hCG levels. The principal therapy is chemotherapy, usually given at a specialized center. With effective chemotherapy, long-term survival exceeds 95%. A unique family with recurrent gestational hyperthyroidism associated with hyperemesis gravidarum was found to have a mutation in the extracellular domain of the TSH receptor that made it responsive to normal levels of hCG.
Hershman
Jerome M
JM
Endocrinology-111D, VA Greater Los Angeles Healthcare Center, 11301 Wilshire Blvd, Los Angeles, CA 90073, USA. jhershmn@ucla.edu
D000595:Amino Acid Sequence; D002822:Choriocarcinoma / Q000453:epidemiology / Q000503:physiopathology*; D006063:Chorionic Gonadotropin / Q000737:chemistry / Q000502:physiology*; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000453:epidemiology / Q000473:pathology* / Q000503:physiopathology*; D008969:Molecular Sequence Data; D011247:Pregnancy; D015995:Prevalence; D013961:Thyroid Gland / Q000473:pathology / Q000503:physiopathology; D014594:Uterine Neoplasms / Q000453:epidemiology / Q000503:physiopathology*
D006063:Chorionic Gonadotropin